What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Medicamen Organics Limited IPO?

Medicamen Organics Limited IPO has received a total subscription of 965.49 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Medicamen Organics Limited

ListedSME

Pharmaceuticals / Healthcare · NSE

Medicamen Organics Limited, founded in 1995, is a trusted pharmaceutical company specializing in the development, manufacturing, and distribution of a wide range of pharmaceutical dosages, including tablets, capsules, syrups, ointments, gels, and dry powders. Catering to both government and private sectors as a contract manufacturer, the company offers 84 products across various therapeutic categories, such as antibacterials, antifungals, antidiabetics, antihypertensives, and multivitamin preparations. Medicamen Organics has a strong domestic presence and exports to multiple international markets, including Africa, CIS, and Southeast Asia. The company operates two WHO-GMP-approved manufacturing facilities in Haridwar, Uttarakhand, spanning 21,536 square feet. With partnerships with 38 domestic contract manufacturers and 12 merchant exporters, the company employed 116 people as of September 30, 2023, ensuring high-quality production and global reach.

Price Band

₹32 – ₹34

Issue Size

₹10.54 Cr

Lot Size

4000 shares

GMP

₹70

+205.9%

Est. Listing

₹104

at current GMP

Subscribed

965.49x

overall

Open

21 Jun 2024

25 Jun 2024

Allotment

26 Jun 2024

Refund

27 Jun 2024

Demat Credit

28 Jun 2024

Listing

28 Jun 2024

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

965.49x

Total Demand

QIB Multiplier

173.03x

Institutions & Funds

NII / HNI

1339.66x

High Net-Worth

Retail (RII)

1255.53x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 965.49x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
QIB	584,000	101,052,000	173.03x
NIB	440,000	589,452,000	1339.66x
RETAIL	1,028,000	1,290,688,000	1255.53x
Total	2,052,000	1,981,192,000	965.49x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 1258.52x

Category	Applications Reserved	Applications Received	Times Subscribed
Retail (RII)	271	340,249	1255.53x
HNIs (10L +)	2	2,679	1339.66x
HNIs (2-10L)	8	10,717	1339.66x
Total Applications	281	353,645	1258.52x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Medicamen Organics Limited Public Issue & Market Profile

Medicamen Organics Limited is bringing an initial public offering (IPO) in the Pharmaceuticals / Healthcare sector with an aggregate issue size of ₹10.54 Crores. The shares are offered at a price band of ₹32 to ₹34 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.

Bidding & Quota Instructions:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 4000 shares (approx. ₹1,36,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Allotment Reconciliation Schedule:

Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2024-06-28, while un-allotted funds or UPI block mandates will be released on 2024-06-27.

Frequently Asked Questions

What is Medicamen Organics Limited IPO GMP today?

The latest Grey Market Premium (GMP) for Medicamen Organics Limited IPO is ₹70 per equity share. Based on the upper price band of ₹32 to ₹34 per equity share, the estimated listing price is ₹104 (+205.9% expected listing gain).

What is the expected profit per lot for Medicamen Organics Limited IPO?

With a lot size of 4000 shares and current GMP of ₹70, the expected profit per application lot is approx ₹2,80,000 (+205.9% gain). Minimum application cost is approx ₹1,36,000.

What is the issue size and price band for Medicamen Organics Limited IPO?

The Medicamen Organics Limited IPO aggregate issue size is ₹10.54 Crores with an equity price band set at ₹32 to ₹34 per equity share. The retail lot size is 4000 shares requiring a minimum capital outlay of approx. ₹1,36,000.

How can I check Medicamen Organics Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 965.49x (Retail: 1255.53x, QIB: 173.03x, NII: 1339.66x). You can track live multiples directly on our dedicated subscription page.

Where and when will Medicamen Organics Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2024-06-26. Investors can verify status using PAN card or application number.

When is the listing date for Medicamen Organics Limited IPO?

Medicamen Organics Limited shares are scheduled to list on NSE on 2024-06-28.